Showing results (1-10 of 5) with videos related to
Sort By:
Pageof 1
Blood|September 29, 2018
EBV/LMP-specific T cells maintain remissions of T- and B-cell EBV lymphomas after allogeneic bone marrow transplantationLauren P McLaughlin, Rayne Rouce, Stephen Gottschalk, et al.Cytotherapy|May 1, 2010
Adverse events following infusion of T cells for adoptive immunotherapy: a 10-year experienceConrad Russell Cruz, Patrick J Hanley, Hao Liu, et al.The Journal of Clinical Investigation|June 9, 2016
Clinical responses with T lymphocytes targeting malignancy-associated κ light chainsCarlos A Ramos, Barbara Savoldo, Vicky Torrano, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 18, 2013
Sustained complete responses in patients with lymphoma receiving autologous cytotoxic T lymphocytes targeting Epstein-Barr virus latent membrane proteinsCatherine M Bollard, Stephen Gottschalk, Vicky Torrano, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 10, 2018
Tumor-Specific T-Cells Engineered to Overcome Tumor Immune Evasion Induce Clinical Responses in Patients With Relapsed Hodgkin LymphomaCatherine M Bollard, Tamara Tripic, Conrad Russell Cruz, et al.Pageof 1